Global GLP-1 Analogues Market Growth 2025-2031
Description
The global GLP-1 Analogues market size is predicted to grow from US$ 2961 million in 2025 to US$ 4452 million in 2031; it is expected to grow at a CAGR of 7.0% from 2025 to 2031.
GLP-1 analogues are a class of medications used in the treatment of type 2 diabetes. They mimic the effects of glucagon-like peptide 1 (GLP-1), which is a hormone produced by the gut that helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion.
United States market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key GLP-1 Analogues players cover Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Analogues Industry Forecast” looks at past sales and reviews total world GLP-1 Analogues sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 Analogues sales for 2025 through 2031. With GLP-1 Analogues sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Analogues industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Analogues landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Analogues portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Analogues market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Analogues and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Analogues.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Analogues market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Exenatide
Liraglutide
Semaglutide
Dulaglutide
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Jiangsu Hansoh Pharmaceutical
Shanghai Benemae Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global GLP-1 Analogues market?
What factors are driving GLP-1 Analogues market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Analogues market opportunities vary by end market size?
How does GLP-1 Analogues break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
GLP-1 analogues are a class of medications used in the treatment of type 2 diabetes. They mimic the effects of glucagon-like peptide 1 (GLP-1), which is a hormone produced by the gut that helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion.
United States market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for GLP-1 Analogues is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key GLP-1 Analogues players cover Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Analogues Industry Forecast” looks at past sales and reviews total world GLP-1 Analogues sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 Analogues sales for 2025 through 2031. With GLP-1 Analogues sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Analogues industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Analogues landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Analogues portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Analogues market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Analogues and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Analogues.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Analogues market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Exenatide
Liraglutide
Semaglutide
Dulaglutide
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Jiangsu Hansoh Pharmaceutical
Shanghai Benemae Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global GLP-1 Analogues market?
What factors are driving GLP-1 Analogues market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Analogues market opportunities vary by end market size?
How does GLP-1 Analogues break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for GLP-1 Analogues by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for GLP-1 Analogues by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
